|
1
|
zur Hausen H: Human papillomaviruses in
the pathogenesis of anogenital cancer. Virology. 184:9–13.
1991.PubMed/NCBI
|
|
2
|
Lee MY, Chou CY, Tang MJ and Shen MR:
Epithelial-mesenchymal transition in cervical cancer: correlation
with tumor progression, epidermal growth factor receptor
overexpression, and snail up-regulation. Clin Cancer Res.
14:4743–4750. 2008. View Article : Google Scholar
|
|
3
|
Hay ED: An overview of
epithelio-mesenchymal transformation. Acta Anat. 154:8–20. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: at the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Oertle T, Merkler D and Schwab ME: Do
cancer cells die because of Nogo-B? Oncogene. 22:1390–1399. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Su Z, Cao L, Zhu Y, et al: Nogo enhances
the adhesion of olfactory ensheathing cells and inhibits their
migration. J Cell Sci. 120:1877–1887. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Qi B, Qi Y, Watari A, et al: Pro-apoptotic
ASY/Nogo-B protein associates with ASYIP. J Cell Physiol.
196:312–318. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kuang E, Wan Q, Li X, Xu H, Zou T and Qi
Y: ER stress triggers apoptosis induced by Nogo-B/ASY
overexpression. Exp Cell Res. 312:1983–1988. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liao H, Duka T, Teng FY, et al: Nogo-66
and myelin-associated glycoprotein (MAG) inhibit the adhesion and
migration of Nogo-66 receptor expressing human glioma cells. J
Neurochem. 90:1156–1162. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Miao RQ, Gao Y, Harrison KD, et al:
Identification of a receptor necessary for Nogo-B stimulated
chemotaxis and morphogenesis of endothelial cells. Proc Natl Acad
Sci USA. 103:10997–11002. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Albig AR and Schiemann WP: Fibulin-5
function during tumorigenesis. Future Oncol. 1:23–35. 2005.
View Article : Google Scholar
|
|
13
|
Nakamura T, Ruiz-Lozano P, Lindner V, et
al: DANCE, a novel secreted RGD protein expressed in developing,
atherosclerotic, and balloon-injured arteries. J Biol Chem.
274:22476–22483. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nakamura T, Lozano PR, Ikeda Y, et al:
Fibulin-5/DANCE is essential for elastogenesis in vivo. Nature.
415:171–175. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Albig AR, Neil JR and Schiemann WP:
Fibulins 3 and 5 antagonize tumor angiogenesis in vivo. Cancer Res.
66:2621–2629. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou S, Xiao W, Wan Q, et al: Nogo-B
mediates HeLa cell adhesion and motility through binding of
Fibulin-5. Biochem Biophys Res Commun. 398:247–253. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Matsukura T and Sugase M: Pitfalls in the
epidemiologic classification of human papillomavirus types
associated with cervical cancer using polymerase chain reaction:
driver and passenger. Int J Gynecol Cancer. 18:1042–1050. 2008.
View Article : Google Scholar
|
|
18
|
Munoz N, Bosch FX, de Sanjose S, et al:
Epidemiologic classification of human papillomavirus types
associated with cervical cancer. N Engl J Med. 348:518–527. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
zur Hausen H: Papillomaviruses and cancer:
from basic studies to clinical application. Nat Rev Cancer.
2:342–350. 2002.PubMed/NCBI
|
|
20
|
Care A, Catalucci D, Felicetti F, et al:
MicroRNA-133 controls cardiac hypertrophy. Nat Med. 13:613–618.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liang X: EMT: new signals from the
invasive front. Oral Oncol. 47:686–687. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Christofori G: New signals from the
invasive front. Nature. 441:444–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huber MA, Kraut N and Beug H: Molecular
requirements for epithelial-mesenchymal transition during tumor
progression. Curr Opin Cell Biol. 17:548–558. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Peinado H, Olmeda D and Cano A: Snail, Zeb
and bHLH factors in tumour progression: an alliance against the
epithelial phenotype? Nat Rev Cancer. 7:415–428. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Christofori G and Semb H: The role of the
cell-adhesion molecule E-cadherin as a tumour-suppressor gene.
Trends Biochem Sci. 24:73–76. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Miettinen PJ, Ebner R, Lopez AR and
Derynck R: TGF-beta induced transdifferentiation of mammary
epithelial cells to mesenchymal cells: involvement of type I
receptors. J Cell Biol. 127:2021–2036. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zavadil J and Bottinger EP: TGF-beta and
epithelial-to-mesenchymal transitions. Oncogene. 24:5764–5774.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li Q, Qi B, Oka K, et al: Link of a new
type of apoptosis-inducing gene ASY/Nogo-B to human cancer.
Oncogene. 20:3929–3936. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Acevedo L, Yu J, Erdjument-Bromage H, et
al: A new role for Nogo as a regulator of vascular remodeling. Nat
Med. 10:382–388. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Van Haastert PJ: How cells use pseudopods
for persistent movement and navigation. Sci Signal.
4:62011.PubMed/NCBI
|
|
31
|
Lee YH, Albig AR, Regner M, Schiemann BJ
and Schiemann WP: Fibulin-5 initiates epithelial-mesenchymal
transition (EMT) and enhances EMT induced by TGF-beta in mammary
epithelial cells via a MMP-dependent mechanism. Carcinogenesis.
29:2243–2251. 2008. View Article : Google Scholar : PubMed/NCBI
|
